Mutations of BRAF and BIRC3 Identify a Subgroup of Chronic Lymphocytic Leukemia with Very Poor Prognosis upon FCR Treatment

被引：0

作者：

Moia, Riccardo ^{[1
]}

Diop, Fary ^{[1
]}

Favini, Chiara ^{[1
]}

Spaccarotella, Elisa ^{[1
]}

De Paoli, Lorenzo ^{[1
]}

Bruscaggin, Alessio ^{[2
]}

Spina, Valeria ^{[2
]}

Cerri, Michaela

Deambrogi, Clara ^{[1
]}

Kodipad, Ahad Ahmed ^{[1
]}

Favini, Simone ^{[1
]}

Sagiraju, Sruthi ^{[1
]}

Jabangwe, Clive ^{[1
]}

Mauro, Francesca Romana ^{[3
]}

Del Giudice, Ilaria ^{[3
]}

Forconi, Francesco ^{[4
,5
,6
]}

Cortelezzi, Agostino ^{[7
,8
]}

Zaja, Francesco ^{[9
]}

Visco, Carlo ^{[10
]}

Chiarenza, Annalisa ^{[11
]}

Rigolin, Gian Matteo ^{[12
]}

Marasca, Roberto ^{[13
]}

Coscia, Marta ^{[14
,15
]}

Perbellini, Omar ^{[16
]}

Tedeschi, Alessandra ^{[17
]}

Laurenti, Luca ^{[18
]}

Motta, Marina ^{[19
]}

Del Poeta, Giovanni ^{[20
]}

Cuneo, Antonio ^{[12
]}

Gattei, Valter ^{[21
]}

Foa, Robin ^{[3
]}

Gaidano, Gianluca ^{[1
]}

Rossi, Davide ^{[2
]}

机构：

[1] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy

[2] Inst Southern Switzerland, Inst Oncol Res & Oncol, Bellinzona, Switzerland

[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy

[4] Univ Southampton, Southampton Canc Res UK, Canc Sci Unit, Southampton, Hants, England

[5] Univ Southampton, Natl Inst Hlth Res, Expt Canc Med Ctr, Southampton, Hants, England

[6] Univ Siena, Div Hematol, Siena, Italy

[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Hematol Oncol, Milan, Italy

[8] Univ Milan, Milan, Italy

[9] Univ Udine, DAME, Clin Ematol, Udine, Italy

[10] Osped San Bortolo, Dept Cell Therapy & Hematol, Vicenza, Italy

[11] Azienda Osped Univ Policlin OVE, Div Hematol, Catania, Italy

[12] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Hematol Sect, Ferrara, Italy

[13] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Div Hematol, Modena, Italy

[14] Azienda Ospedaliero Univ Citta Salute & Sci, Div Hematol, Turin, Italy

[15] Univ Turin, Turin, Italy

[16] Univ Verona, Dept Med, Sect Hematol, Verona, Italy

[17] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Dept Oncol Haematol, Milan, Italy

[18] Univ Cattolica Sacro Cuore, Inst Hematol, Rome, Italy

[19] Spedali Civil Brescia, Dept Hematol, Brescia, Italy

[20] Tor Vergata Univ, Dept Hematol, Rome, Italy

[21] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, Italy

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 10期

关键词：

chronic lymphocytic leukemia; FCR; immunochemotherapy; molecular predictors; precision medicine;

D O I：

10.1016/j.clml.2017.09.039

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CLL-009

引用

页码：S11 / S12

页数：2

共 50 条

[1] BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia
Diop, Fary
Moia, Riccardo
Favini, Chiara
Spaccarotella, Elisa
De Paoli, Lorenzo
Bruscaggin, Alessio
Spina, Valeria
Cerri, Michaela
Deambrogi, Clara
Kodipad, Ahad Ahmed
Favini, Simone
Sagiraju, Sruthi
Jabangwe, Clive
Mauro, Francesca Romana
Del Giudice, Ilaria
Forconi, Francesco
Cortelezzi, Agostino
Zaja, Francesco
Visco, Carlo
Chiarenza, Annalisa
Rigolin, Gian Matteo
Marasca, Roberto
Coscia, Marta
Perbellini, Omar
Tedeschi, Alessandra
Laurenti, Luca
Motta, Marina
Del Poeta, Giovanni
Cuneo, Antonio
Gattei, Valter
Foa, Robin
Gaidano, Gianluca
Rossi, Davide
BLOOD, 2017, 130
[2] BIRC3 mutations in chronic lymphocytic leukemia - uncommon and unfavorable
Tausch, Eugen
Stilgenbauer, Stephan
HAEMATOLOGICA, 2020, 105 (02) : 255 - 256
[3] Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
Diop, Fary
Moia, Riccardo
Favini, Chiara
Spaccarotella, Elisa
De Paoli, Lorenzo
Bruscaggin, Alessio
Spina, Valeria
Terzi-di-Bergamo, Lodovico
Arruga, Francesca
Tarantelli, Chiara
Deambrogi, Clara
Rasi, Silvia
Adhinaveni, Ramesh
Patriarca, Andrea
Favini, Simone
Sagiraju, Sruthi
Jabangwe, Clive
Kodipad, Ahad A.
Peroni, Denise
Mauro, Francesca R.
Del Giudice, Ilaria
Forconi, Francesco
Cortelezzi, Agostino
Zaja, Francesco
Bomben, Riccardo
Rossi, Francesca Maria
Visco, Carlo
Chiarenza, Annalisa
Rigolin, Gian Matteo
Marasca, Roberto
Coscia, Marta
Perbellini, Omar
Tedeschi, Alessandra
Laurenti, Luca
Motta, Marina
Donaldson, David
Weir, Phil
Mills, Ken
Thornton, Patrick
Lawless, Sarah
Bertoni, Francesco
Del Poeta, Giovanni
Cuneo, Antonio
Follenzi, Antonia
Gattei, Valter
Boldorini, Renzo Luciano
Catherwood, Mark
Deaglio, Silvia
Foa, Robin
Gaidano, Gianluca
HAEMATOLOGICA, 2020, 105 (02) : 448 - 456
[4] BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients
Alhourani, Eyad
Othman, Moneeb A. K.
Melo, Joana B.
Carreira, Isabel M.
Grygalewicz, Beata
Vujic, Dragana
Zecevic, Zeljko
Joksic, Gordana
Glaser, Anita
Pohle, Beate
Schlie, Cordula
Hauke, Sven
Liehr, Thomas
ONCOLOGY LETTERS, 2016, 11 (05) : 3240 - 3246
[5] Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease
Raponi, Sara
Del Giudice, Ilaria
Ilari, Caterina
Cafforio, Luciana
Messina, Monica
Cappelli, Luca V.
Bonina, Silvia
Piciocchi, Alfonso
Marinelli, Marilisa
Peragine, Nadia
Mariglia, Paola
Mauro, Francesca R.
Rigolin, Gian M.
Rossi, Francesca
Bomben, Riccardo
Dal Bo, Michele
Del Poeta, Giovanni
Diop, Fary
Favini, Chiara
Rossi, Davide
Gaidano, Gianluca
Cuneo, Antonio
Gattei, Valter
Guarini, Anna
Foa, Robin
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 156 - 159
[6] Recurrent ATM and BIRC3 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) and Deletion 11q22-q23
Grossmann, Vera
Kohlmann, Alexander
Schnittger, Susanne
Weissmann, Sandra
Jeromin, Sabine
Kienast, Jennifer
Kern, Wolfgang
Haferlach, Torsten
Haferlach, Claudia
BLOOD, 2012, 120 (21)
[7] Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations In chronic lymphocytic leukemia
Rasi, Silvia
Khiabanian, Hossein
Ciardullo, Carmela
Terzi-di-Bergamo, Lodovico
Monti, Sara
Spina, Valeria
Bruscaggin, Alessio
Cerri, Michaela
Deambrogi, Clara
Martuscelli, Lavinia
Biasi, Alessandra
Spaccarotella, Elisa
De Paoli, Lorenzo
Gattei, Valter
Foa, Robin
Rabadan, Raul
Gaidano, Gianluca
Rossi, Davide
HAEMATOLOGICA, 2016, 101 (04)
[8] Small Subclones Harboring NOTCH1, SF3B1 or BIRC3 Mutations Are Clinically Irrelevant in Chronic Lymphocytic Leukemia
Rossi, Davide
Khiabanian, Hossein
Rasi, Silvia
Ciardullo, Carmela
di Bergamo, Lodovico Terzi
Monti, Sara
Spina, Valeria
Biasi, Alessandra
De Paoli, Lorenzo
Gattei, Valter
Foa, Robin
Rabadan, Raul
Gaidano, Gianluca
BLOOD, 2014, 124 (21)
[9] Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia
Fangazio, Marco
Rasi, Silvia
Vaisitti, Tiziana
Monti, Sara
Cresta, Stefania
Bruscaggin, Alessio
Spina, Valeria
Forconi, Francesco
Chiaretti, Sabina
Guarini, Anna
Deaglio, Silvia
Foa, Robin
Gaidano, Gianluca
Rossi, Davide
BLOOD, 2011, 118 (21) : 216 - 216
[10] Clinical Impact of Clonal and Subclonal TP53, SF3B1, BIRC3, and ATM Mutations in Chronic Lymphocytic Leukemia
Nadeu, Ferran
Delgado, Julio
Royo, Cristina
Bauman, Tycho
Stankovic, Tatjana
Pinyol, Magda
Jares, Pedro
Navarro, Alba
Martin-Garcia, David
Bea, Silvia
Salaverria, Itziar
Oldreive, Ceri
Aymerich, Marta
Suarez-Cisneros, Helena
Rozman, Maria
Villamor, Neus
Colomer, Dolors
Lopez-Guillermo, Armando
Gonzalez, Marcos
Alcoceba, Miguel
Jose Terol, Maria
Colado, Enrique
Puente, Xose S.
Lopez-Otin, Carlos
Enjuanes, Anna
Campo, Elias
BLOOD, 2015, 126 (23)

← 1 2 3 4 5 →